asparagine has been researched along with Myocardial Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bresciani, P; Ferrari, A; Luppi, M; Morselli, M; Potenza, L; Riva, G; Saviola, A; Torelli, G | 1 |
| Bujac, SR; Hall, S; Humphries, SE; Miller, GJ; Talmud, PJ | 1 |
2 other study(ies) available for asparagine and Myocardial Ischemia
| Article | Year |
|---|---|
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Daunorubicin; Echocardiography; Humans; Male; Myocardial Ischemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; Vincristine | 2004 |
Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers.
Topics: Asparagine; Aspartic Acid; Confidence Intervals; Genotype; Heterozygote; Humans; Lipoprotein Lipase; Male; Middle Aged; Myocardial Ischemia; Population Surveillance; Proportional Hazards Models; Prospective Studies; Reference Values; Risk Assessment; Smoking | 2000 |